Escin IA

Escin IA
Product Name Escin IA
CAS No.: 123748-68-5
Catalog No.: CFN93368
Molecular Formula: C55H86O24
Molecular Weight: 1131.3 g/mol
Purity: >=98%
Type of Compound: Triterpenoids
Physical Desc.: Powder
Targets: LOX | TNF-α | TGF-β/Smad | HIF
Source: The herbs of Aesculus hippocastanum L.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $100/20mg
Escin IA is a prodrug and its structure can be converted to desacylescin I by human intestinal bacteria and Lactobacillus brevis., desacylescin I as a biotransformation product shows potentially inhibitory effects on mouse tumor, and a potential candidate for anti tumor agents. Escin IA has anti-TNBC metastasis activity, and its action mechanisms involved inhibition of EMT process by down-regulating LOXL2 expression.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Plants (Basel).2021, 10(11):2525.
  • Universiti Tunku Aboul Rahman2023, 6263.
  • Academic J of Second Military Medical University2019, 40(1)
  • Bioinformatics 2024, 586957
  • Int. J. Mol. Sci.2022, 23(19), 11900.
  • Antioxidants (Basel).2019, 8(8):E307
  • Enzyme Microb Technol.2022, 153:109941.
  • Life (Basel).2022, 12(12):2107.
  • Molecules.2022, 27(4):1412.
  • J Med Food.2016, 19(12):1155-1165
  • Escin IB

    Catalog No: CFN90934
    CAS No: 26339-90-2
    Price: $238/20mg
    Deacylgymnemic acid

    Catalog No: CFN70258
    CAS No: 121686-42-8
    Price: Inquiry(manager@chemfaces.com)
    Gymnemic acid I

    Catalog No: CFN90538
    CAS No: 122168-40-5
    Price: Inquiry(manager@chemfaces.com)
    Escin IA

    Catalog No: CFN93368
    CAS No: 123748-68-5
    Price: $100/20mg
    Isoescin IA

    Catalog No: CFN90932
    CAS No: 219944-39-5
    Price: $238/20mg
    Isoescin IB

    Catalog No: CFN90933
    CAS No: 219944-46-4
    Price: $268/10mg
    Aescin IIA

    Catalog No: CFN94818
    CAS No: 158732-55-9
    Price: Inquiry(manager@chemfaces.com)
    Theasaponin E2

    Catalog No: CFN91688
    CAS No: 220114-30-7
    Price: Inquiry(manager@chemfaces.com)
    Theasaponin E1

    Catalog No: CFN91689
    CAS No: 220114-28-3
    Price: Inquiry(manager@chemfaces.com)
    Sodium Aescinate

    Catalog No: CFN99509
    CAS No: 20977-05-3
    Price: Inquiry(manager@chemfaces.com)
    Oncotarget, 2016, 7(17):23684-99.
    Escin Ia suppresses the metastasis of triple-negative breast cancer by inhibiting epithelial-mesenchymal transition via down-regulating LOXL2 expression[Pubmed: 27008697 ]

    METHODS AND RESULTS:
    The saponin fraction of Aesculus chinensis Bunge fruits (SFAC) could inhibit the invasion and migration of MDA-MB-231 cells. Among which, Escin IA showed more potent inhibition of the invasion than other five main saponin constituents. It selectively reduced the expression of LOXL2 mRNA and promoted the expression of E-cadherin mRNA, and prevented the EMT process of MDA-MB-231 cells and TNF-α/TGF-β-stimulated MCF-7 cells. Moreover, it reduced the LOXL2 level in MDA-MB-231 cells but not in MCF-7 cells. When MCF-7 cells were stimulated with TNF-α/TGF-β, transfected with LOXL2 or treated with hypoxia, Escin IA down-regulated the level of LOXL2 in MCF-7 cells. Meanwhile, Escin IA suppressed the EMT process in LOXL2-transfected or hypoxia-treated MCF-7 cells. Of interest, Escin IA did not alter the level of HIF-1α in hypoxia-induced MCF-7 cells.In TNBC xenograft mice, the metastasis and EMT of MDA-MB-231 cells were suppressed by Escin IA.
    CONCLUSIONS:
    In conclusion, Escin IA was the main active ingredient of SFAC for the anti-TNBC metastasis activity, and its action mechanisms involved inhibition of EMT process by down-regulating LOXL2 expression.
    Beijing Da Xue Xue Bao. 2004,36(1):31-5.
    Studies on the biotransformation of escin Ia by human intestinal bacteria and the anti-tumor activities of desacylescin I[Pubmed: 14970884]
    To study Biotransformation of Escin IA by the crude enzymes of human intestinal bacteria and Lactobacillus brevis, determine the structures of biotransformation products and assay the inhibitory effect of desacylescin I on the tumor cell growth.
    METHODS AND RESULTS:
    The Escin IA was incubated with crude enzymes of human intestinal bacteria and Lactobacillus brevis in vitro, respectively. The biotransformation products were isolated and purified by the chromatographic methods and the structures were determined by the spectroscopic techniques. Escin IA was converted into isoEscin IA, desacylescin I, 21beta-O-tigloylprotoaescigenin and protoaescigenin by crude enzymes of human intestinal bacteria and Lactobacillus brevis. Desacylescin I showed potentially inhibitory effects on tumor cell growth of mouse sarcoma-180, hepatic carcinoma H(22) and lung carcinoma in vivo.
    CONCLUSIONS:
    The results suggest that Escin IA was a prodrug and its structure can be converted by human intestinal bacteria and Lactobacillus brevis. Desacylescin I as a biotransformation product showed potentially inhibitory effects on mouse tumor, and a potential candidate for anti tumor agents.
    Mirificin-4'-O-glucoside

    Catalog No: CFN95091
    CAS No: 168035-01-6
    Price: $288/5mg
    Arvenin III

    Catalog No: CFN95327
    CAS No: 65597-45-7
    Price: $318/5mg
    Dioscoreside C

    Catalog No: CFN95345
    CAS No: 344912-80-7
    Price: $318/5mg
    Kaempferol 3,4'-di-O-glucoside

    Catalog No: CFN95357
    CAS No: 71939-16-7
    Price: $318/5mg
    Oxytroflavoside D

    Catalog No: CFN95491
    CAS No: 1391144-83-4
    Price: $318/10mg
    trans-Cinnamoyl beta-D-glucoside

    Catalog No: CFN95497
    CAS No: 13080-39-2
    Price: Inquiry(manager@chemfaces.com)
    Hosenkoside D

    Catalog No: CFN95521
    CAS No: 156823-94-8
    Price: $318/5mg
    1-Phenylethyl beta-D-glucoside

    Catalog No: CFN95574
    CAS No: 93199-03-2
    Price: $318/5mg
    Mahuannin E

    Catalog No: CFN95585
    CAS No: 1173887-70-1
    Price: $318/5mg
    11-Keto-ganoderic acid DM

    Catalog No: CFN95593
    CAS No: N/A
    Price: $413/5mg